Episode Details
Back to Episodes
Therapeutic Vaccine Halts Brain Tumor Recurrence | Europe News
Description
A breakthrough therapeutic vaccine is showing real promise in fighting aggressive brain tumors—by training the immune system to hunt down cancer cells that survive initial treatment. Targeting a unique protein born from a specific genetic mutation, the vaccine spurs T and B cells to attack residual tumor cells, aiming to prevent recurrence. In a landmark eight-year follow-up study, 66% of 33 patients remained alive, and 42% showed no tumor regrowth—huge wins for a cancer notorious for returning. While cautious optimism is warranted, a new trial set for 2027 will explore long-term effects and booster potential, offering renewed hope for patients facing this devastating diagnosis.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/6443a1e73314e485